This is because the cellular protein factories are usually forced to produce heterologous polypeptides, encoded in a multicopy expression plasmid, over physiological rates Keywords aggre
Trang 1Biological role of bacterial inclusion bodies: a model for amyloid aggregation
Elena Garcı´a-Fruito´s1–3,*, Raimon Sabate1,4,*, Natalia S de Groot1,4, Antonio Villaverde1–3and Salvador Ventura1,4
1 Institute for Biotechnology and Biomedicine, Universitat Auto`noma de Barcelona, Spain
2 Department of Genetics and Microbiology, Universitat Auto`noma de Barcelona, Spain
3 CIBER de Bioingenierı´a, Biomateriales y Nanomedicina (CIBER-BBN), Barcelona, Spain
4 Department of Biochemistry and Molecular Biology, Universitat Auto`noma de Barcelona, Spain
Biotechnology of bacterial inclusion
bodies; a historical view
Production of recombinant proteins in
microorgan-isms, powered in the late 1970s by the identification of
restriction enzymes, has provided much fewer products
than initially expected [1] The ready-to-use concept of
recombinant DNA technologies has proved to be
unre-alistic and has faced severe obstacles associated with the physiology of the host microorganism This is because the cellular protein factories are usually forced
to produce heterologous polypeptides, encoded in a multicopy expression plasmid, over physiological rates
Keywords
aggregation; amyloid; FTIR; inclusion bodies;
protein folding; protein quality; recombinant
proteins
Correspondence
A Villaverde, Institute for Biotechnology and
Biomedicine, Universitat Auto`noma de
Barcelona, Bellaterra, 08193 Barcelona,
Spain
Fax: +34 93 581 2011
Tel: +34 93 581 2148
E-mail: Antoni.Villaverde@uab.cat
S Ventura, Institute for Biotechnology and
Biomedicine, Universitat Auto`noma de
Barcelona, Bellaterra, 08193 Barcelona,
Spain
Fax: +34 93 581 2011
Tel: +34 93 586 8956
E-mail: salvador.ventura@uab.es
*These authors contributed equally to this
work
(Received 28 January 2011, revised 18
March 2011, accepted 15 April 2011)
doi:10.1111/j.1742-4658.2011.08165.x
Inclusion bodies are insoluble protein aggregates usually found in recombi-nant bacteria when they are forced to produce heterologous protein species These particles are formed by polypeptides that cross-interact through sterospecific contacts and that are steadily deposited in either the cell’s cytoplasm or the periplasm An important fraction of eukaryotic proteins form inclusion bodies in bacteria, which has posed major problems in the development of the biotechnology industry Over the last decade, the fine dissection of the quality control system in bacteria and the recognition of the amyloid-like architecture of inclusion bodies have provided dramatic insights on the dynamic biology of these aggregates We discuss here the relevant aspects, in the interface between cell physiology and structural biology, which make inclusion bodies unique models for the study of pro-tein aggregation, amyloid formation and prion biology in a physiologically relevant background
Abbreviations
IB, inclusion body; PFD, prion forming domain.
Trang 2– a combination of facts that tend to saturate the
pro-tein synthesis machinery and activate the quality
con-trol system Essentially, protein production processes
in bacteria (as well as in other microorganisms) suffer
from protein degradation and lack of solubility and, to
a minor extent, toxicity exerted by the product on the
cells and consequent genetic instability (including
plas-mid loss) These events occur in the context of several
cell stress responses, which depending on the nature of
the host microorganism include triggering of oxidative
stress, the unfolded protein response, the heat shock
and the stringent response and the activation of the
DNA repair SOS system [2]
Traditionally, lack of solubility and the formation of
inclusion bodies (IBs), large insoluble clusters enriched
by misfolded versions of the recombinant protein
spe-cies [3], have been the main obstacle for the smooth
consecution of production processes, aimed at high
yields of soluble, biologically active species Believed to
be irreversibly formed and containing inactive proteins,
how to minimize IB formation in midstream has been
a matter of extensive discussion Essentially, reducing
the growth temperature, lowering the transcription rate
and co-producing folding modulators selected from the
quality control system have been thoroughly explored
strategies [4] Also, at the downstream level, refolding
of IB proteins has also been approached [5] Both
mid-stream- and downmid-stream-focused approaches have
been successful for an important number of specific
proteins but they do not offer generic solutions to the lack of solubility in protein production
Despite the economical relevance of IB formation for both catalysis and biotech industries, IBs have been
in general poorly characterized Consequently, the dis-covery of the reversibility of IB formation [6], the gen-eral acceptance of IBs being formed by functional proteins [7] and the recognition of the amyloid-like architecture of IB proteins [8] have represented dra-matic insights in the biology of these structures that has favoured important advances in the comprehension
of their physiological and structural nature For instance, the conceptual unlinking between solubility and functional quality [9], and the fact that enhanced protein yields result in lower quality protein species [10,11], has permitted IBs to be explored as powerful biocatalysts (the embedded proteins acting as immobi-lized enzymes) [12,13] On the other hand, the fine and timely analysis of the amyloid architecture of IB proteins [14,15] has led to the use of these underesti-mated bacterial aggregates as intriguing models for the analysis of protein–protein interactions in the context
of amyloid and prion diseases
Dynamics of IB formation and biological activity
Intracellular electrodense proteinaceous granules had been observed in classical experiments when bacteria
Soluble VP1LAC + (1/10) VP1LAC IBs Soluble VP1LAC + (1/10) TSP IBs Soluble VP1LAC + (1/10) SPC-PI3DT IBs Soluble VP1LAC + (1/10) HIVP IBs Soluble LACZ
Soluble LACZ + (1/10) VP1LAC IBs
B
A
C
Fig 1 A nucleation ⁄ polymerization self-assembly process drives the formation of IBs in bacteria (A) In vivo formation of IBs
in recombinant bacteria Aggregation-prone versions of the recombinant protein (green) slowly form seeding nuclei by cross-molecu-lar stereospecific interactions These proto-aggregates recruit further copies of the tar-get protein, in a process compatible with first-order kinetics This promotes a fast mass growth of IBs Non-homologous cellu-lar or recombinant proteins (red, black) are excluded from these seeding events (B) Kinetics of aggregation monitored by time-dependent increase of turbidity at 350 nm using soluble VP1LAC and LACZ incubated with different IBs (figure modified from [8]) (C) Kinetics of Ab42 peptide seeding moni-tored through thioflavin-T fluorescence emis-sion (figure taken from [58]) All figures have been reproduced with permission.
Trang 3were cultured in the presence of non-natural amino
acids This observation, which indicated the transient
nature of protein aggregates formed by
conformation-ally aberrant proteins, was more recently repeated with bacterial IBs [6], so far believed to be irreversible pro-tein clusters averse to in vivo propro-tein refolding [16]
200 nm
50 nm
0.2
0.4
0.6
CRfree
CR +
CR +
CR + HET-s (001–289) HET-s (157–289)
HET-s (218–289)
375 475 575 675
0.0
Wavelength (nm)
0.3 CR +
CR +
HET-s (001–289)
0.8 1.0
1600 1620 1640 1660 1680 1700 0.0 0.2 0.4 0.6
0.001 1628 cm
–1
Inter β-sheet band
1600 1620 1640 1660 1680 1700 –0.005 –0.003 –0.001
Wavenumber (cm –1 ) Wavenumber (cm –1 )
50 nm
375 475 575 675
–0.1
0.0
0.1
0.2
CR +
Wavelength (nm)
HET-s (157–289)
HET-s (218–289)
≈ 540 nm
50 nm
15
190 200 210 220 230 240 250 –10
–5 0 5 10
Wavelength (nm)
2 ·dmol
0 50 100 150 200 0.0
0.2 0.4 0.6 0.8 1.0
Without IBs
HET-s Full length IBs HET-s PFD IBs [HET-s PFD] = 10 μ M
Time (min)
A
C
I
J
K
F
D
H B
Fig 2 Presence of amyloid-like structures in the IBs formed by the prion protein HET-s from P anserina (A) HET-s PFD IBs from E coli observed by cryo-electron microscopy in intact E coli cells (B) Transmission electron micrograph of negatively stained purified HET-s PFD IBs (C), (D) HET-s IB structure before (C) and after (D) 30 min of proteinase K digestion monitored by transmission electron microscopy, showing the apparition of fibrillar structures (E)–(H) Congo Red (CR) binding to different HET-s IBs monitored by UV ⁄ vis spectroscopy and staining and birefringence under cross-polarized light using an optical microscope: (E), (F) CR spectral changes in the presence of different HET-s IBs; (E) changes in kmaxand intensity in CR spectra in the presence of HET-s IBs; (F) difference absorbance spectra of CR in the pres-ence and abspres-ence of IBs showing in all cases the characteristic amyloid band at 540 nm; (G) HET-s PFD IBs stained with CR and observed at 40· magnification and (H) the same field observed between crossed polarizers displaying the green birefringence characteristic
of amyloid structures (I) 13 C– 13 C solid-state NMR correlation spectrum (proton-driven spin-diffusion with a mixing time of 50 ms) of purified HET-s PFD IBs (blue) compared with a spectrum of in vitro HET-s PFD amyloid fibrils (red) recorded under identical conditions All the signals assigned for the purified fibrils were also observed in the spectrum of the IBs The insets demonstrate that no significant changes in the chemical shifts appear and that the linewidths of the two samples are virtually identical The individual spectra were recorded at a 1H fre-quency of 600 MHz (static field B 0 = 14.9 T), 10 kHz magic angle spinning (J)–(L) Secondary structure of HET-s PFD IBs: (J) CD spectra, and (K), (L) FTIR absorbance and second derivative spectra in the amide I region of HET-s PFD spectra showing the characteristic spectral bands of b-sheet conformations (M) Seeding-dependent maturation of HET-s PFD amyloid growth The aggregation reaction was seeded with HET-s full length, HET-s (157–289), HET-s PFD, Ab40 or Ab42 IBs The fibrillar fraction of HET-s PFD is represented as a function of time The formation of HET-s PFD amyloid fibrils is accelerated only in the presence of HET-s IBs (A), (B) and (I) adapted, with permission, from [60]; (C)–(H) and (J)–(M) adapted, with permission, from [15].
Trang 4This is indicative of cellular activities acting on these
protein aggregates, including release to the soluble cell
fraction but also proteolytic events [6,17,18] that might
promote degradation of IB proteins in situ [19] In
addition, for protein species that are found in both
sol-uble and insolsol-uble cell fractions, the conformational
quality and biological activity of IB embedded proteins
evolve in parallel with those of the soluble
counter-parts, under different environmental conditions
affect-ing foldaffect-ing, such as temperature and chaperone
availability [20,21] Therefore, IB proteins appear not
to be excluded from quality control [22], in which a
complex network of chaperones and proteases survey
the folding status of cellular proteins [23], soluble but
also insoluble
In agreement with this concept, the main Escherichia
coli chaperone DnaK (a holding agent and a foldase
and disaggregase), is almost exclusively found, in
IB-producing bacteria, attached at the IB surface, while
the foldase GroEL is present within the IB core [24]
DnaK, which participates in the in vivo refolding of
bacterial thermal aggregates [25,26], appears to be
highly active on bacterial IBs [20,27,28] In fact, we
have recently shown that the chaperone DnaK
pro-motes protein extraction from bacterial IBs but that
this event is intimately associated with proteolysis
[10,11] This explains the reduction of protein yield
eventually observed during co-production of this
chap-erone and others [10], as a side effect of this strategy
[29] addressed to improve the solubility of recombinant
proteins Interestingly, the specific dependence of the
DnaK-mediated stimulation on bacterial chaperones
makes this chaperone very useful for co-production in
eukaryotic systems [30]
The simultaneous surveillance of soluble and IB
pro-tein species by bacterial chaperones and proteases
indi-cates the occurrence of similar targets in both protein
versions and strongly suggests a highly dynamic
transi-tion between the two forms In fact, aggregatransi-tion and
disaggregation seem to be simultaneous events in
actively producing recombinant bacteria [16], while
dis-aggregation will be highly favoured in the absence of
protein synthesis [6] Such a bidirectional protein
tran-sit between the cells’ virtual fractions (soluble and
insoluble [22]) accounts for the unexpected and
recently determined abundance of soluble aggregates in
recombinant cells [31] These particles, either globular
or fibrillar, might be intermediates in the in⁄ out IB
protein transition, or just members of the
conforma-tional spectrum that recombinant proteins can adopt
in host bacteria, irrespective of whether they are found
in soluble or insoluble cell fractions Interestingly,
increasing evidence supports the presence of
biologi-cally active proteins embedded in IBs, indicating that both folded and misfolded polypeptides coexist
in these proteinaceous aggregates [32] Regarding the presence of functional protein in such aggregates, different enzyme-based IBs have been successfully tested as catalysts of different bioprocesses [33] Galac-tosidases [7,34], reductases [7], oxidases [35], kinases [36], phosphorylases [37] and aldolases [38] are just some examples of the enzymes used in aggregated form
to catalyse specific reactions, opening a promising mar-ket in the biotechnological industry [33] In this con-text, other authors have also described the use of IBs for the intracellular capture of a co-synthesized target enzyme, obtaining IB particles with the enzyme of interest immobilized in their surface [39]
Stereospecific interactions in protein aggregation
Chiti and coworkers pointed out that the intrinsic physicochemical properties of an amino acid sequence, such as hydrophobicity, secondary structure propensity and charge, can determine the aggregation behaviour
of a given polypeptide [40,41] Many examples support the correlation between protein aggregation tendency and amino acid sequence, and it is also possible to identify the aggregation-prone regions of polypeptides using software such as aggrescan [42] or tango [43] Protein aggregation can be understood as an anoma-lous type of protein–protein interaction As for native interactions, the attainment of ordered aggregated structures requires the establishment of stereospecific intermolecular contacts Accordingly, it has been observed that both bacterial [8] and mammalian pro-tein aggregates are formed through a conserved, selec-tive and sequence-specific process Specificity during protein aggregation is best exemplified by the nucle-ation-driven polymerization of proteins into amyloid aggregates [44], a mechanism reminiscent of that occurring in crystallization processes [45] Mature amy-loid fibrils possess the faculty to accelerate the forma-tion of new fibrils by acting as a nucleus that seeds the growth of fibrillar structures [46] However, molecular recognition between aggregated and soluble proteins only occurs when they share a high sequence similar-ity The requirement for stereospecific interactions during protein aggregation would explain why disease-linked amyloid deposits are composed almost exclu-sively of the pathogenic protein [47] and bacterial IBs are highly enriched in the target recombinant protein [22] The distribution of side chains in the sequence, such as occurs in protein folding, plays a pivotal role
in determining the conformational properties of the
Trang 5aggregated state and the way in which this
supramolec-ular ensemble is reached from the initial soluble state
This control is so exquisite that a protein and its
backward version (a protein with exactly the same
succession of side chains but with a reverted backbone)
do not cross seed each other and form aggregates
dis-playing different conformational and functional
prop-erties [48] However, apart from the primary sequence,
the particular structural and thermodynamic properties
of proteins modulate their deposition in physiologically
relevant conditions, making it difficult to predict the
effective aggregation propensities of polypeptides in
cellular environments
Protein aggregation into amyloid
structures
Protein aggregation can occur from multiple structural
conformations such as intrinsically disordered
polypep-tides, oligomeric species or globular proteins [47,49]
The macromolecular assemblies formed by these
pro-teins are all sustained by intermolecular interactions
but their arrangement and specificity define the degree
of order in the structure of the final aggregate The
energy landscape of protein aggregation is rough and
complex, comprising both highly energetic amorphous
deposits and well-ordered amyloid fibrils of lower
energy than the native structure of the protein [50,51]
Amorphous aggregates can be formed rapidly by
sim-ple precipitation of the protein, whereas ordered
fibril-lation requires specific intermolecular contacts, the
formation of which is strongly influenced by the
pro-tein local environment [47,52]
The number of identified amyloid-forming proteins
increases each year These fibrillar structures were
initially discovered in human tissues of patients
suffering from amyloidoses such as Alzheimer’s or
Parkinson’s diseases The study of these deposits has
shown that mature fibrils can be less cytotoxic than
the intermediary forms in the aggregation pathway
suggesting that the amyloid structure might play in
fact a protective function [47,53] Importantly,
amy-loid conformations are not only associated with
path-ological conditions but are also exploited by Nature
to execute important regulatory, structural and
genetic functions [54,55] In fact, the ability to form
amyloid assemblies has been suggested to be a
gen-eric protein property [47,56] and, as we shall see in
the next sections, a conformation accessible to
struc-turally and sequentially unrelated proteins upon
recombinant expression [51]
Despite their diverse origin, all amyloid structures
share common morphological characteristics: straight
unbranched fibrils 7–12 nm in diameter made up of two to six protofilaments 2–5 nm in diameter with a cross-b-sheet spine [47,57] in which each polypeptide chain is structured into b-strands and each b-strand is arranged perpendicular to the long axis of the fibril This arrangement allows a tightly packed quaternary structure sustained mainly by generic hydrogen bonds and hydrophobic contacts [58], explaining why, in spite
of the high sequential specificity driving amyloid for-mation pathways, any sequence able to be accommo-dated in a b-sheet conformation can, potentially, reach the amyloid state [51,56]
Amyloid-like properties of bacterial IBs
The architecture and mechanisms of IB formation in bacteria have remained unexplored for years However, important insights in this field have lately emerged Although IBs were conventionally described as disor-dered aggregates being formed by non-specific interac-tions of exposed hydrophobic surfaces, an increasing amount of evidence is showing that in fact IBs are highly ordered protein deposits formed through a process simi-lar to that observed during amyloid deposition [8,14] Just as occurs for amyloids, IB formation is driven by intermolecular interactions occurring through homolo-gous protein patches in a nucleation-dependent manner (Figure 1) [8] On the one hand, a study published by Carrio´ and coworkers demonstrates that target recombi-nant protein aggregation in vitro is a tightly regulated phenomenon, and recombinant proteins preferentially associate with themselves rather than with other pro-teins in the environment in a dose-dependent way [8]
On the other hand, an in vivo study performed using fluorescence resonance energy transfer shows that, when co-producing two different recombinant proteins in the complex bacterial cytoplasmic environment, the distri-bution of the two proteins in the formed IBs is also tightly regulated through specific contacts, each protein being specifically localized in a different region of the aggregate depending on its sequence Therefore, it is not surprising that, in spite of the IBs’ amorphous macro-scopic appearance, recently different groups have con-verged to demonstrate unequivocally the effective existence of amyloid-like structures inside bacterial aggregates [14,59] Accordingly, relative to the native conformation, proteins embedded in IBs appear to be enriched in b-sheet secondary structure elements dis-playing the minimum at 217 nm characteristic of this conformation in the far-UV circular dichroism spectra (which can be displaced slightly to higher wavelengths due to the stacking of aromatic residues) as well as a band at 1620–1630 cm)1in the infrared spectra, typical
Trang 6of the tightly bound intermolecular b-strands in amyloid
structures [8,15,59–61], and X-ray diffraction patterns
with meridional (4.8 A˚) and equatorial (10–11 A˚)
reflec-tions compatible with the presence of a cross-b structure
[59] In addition, amyloid-specific dyes like Congo Red
or thioflavin-T and S bind to bacterial IBs with similar
affinity to the affinity they exhibit for amyloid structures
[8,15,59–61], confirming a high degree of
conforma-tional similarity between the two types of aggregates As
in amyloid fibrils, IBs display regions with high
resis-tance against proteolytic attack, probably
correspond-ing to a preferentially protected b-sheet core The
presence of fibrillar structures with amyloid-like
mor-phology in IBs has been observed directly or after
con-trolled proteolytic digestion by transmission electronic
microscopy, cryo-electron microscopy [59,62] and
atomic force microscopy [15,60,61] In addition, IBs
formed by amyloid proteins display the capacity to seed
and accelerate in a highly specific manner the formation
of amyloid structures by their soluble and monomeric
forms [15,60–62] (see Figure 2)
Aggregated structures are non-crystalline and
insolu-ble and are therefore not amenainsolu-ble to X-ray
crystallog-raphy and solution NMR, the classical tools of
structural biology, making it difficult to characterize
the fine structure of these assemblies at the residue
level, even when they display a high degree of internal
order [63] Quenched hydrogen⁄ deuterium exchange
with solution NMR allows the identification of
sol-vent-protected backbone amide protons involved in
hydrogen bonds Interestingly enough, three recent
studies using this approach to study the IBs formed by
different protein models convincingly demonstrate
the presence of sequence-specific motifs displaying
protection compatible with a cross-b conformation
[59,61,62] High resolution information on the
confor-mation of proteins in the aggregated state can be
obtained by solid-state NMR, a technique that has
allowed amyloid fibrils to be modelled at atomic
reso-lution [64] Two recent works have exploited solid-state
NMR to address the fine structure of the IBs formed
by two amyloidogenic proteins, the HET-s prion
form-ing domain (PFD) of the fungus Podospora anserina
and the Alzheimer’s amyloid b peptide (Ab) The
com-parison between the signals of the in vitro formed
amy-loid fibrils and the corresponding IBs indicates the
existence of regions with highly similar structural
dis-position in these aggregates, in particular in the case of
HET-s PFD where the NMR signals of the two types
of aggregates overlap significantly [61,62,65] Overall,
it appears that the formation of amyloid-like
assem-blies is an omnipresent process in both eukaryotic and
prokaryotic cells
Infectious conformations in bacterial IBs
Prions represent a particular subclass of amyloids in which the aggregation process becomes self-perpetuat-ing in vivo and thus infectious [14] The possibility that the bacterial IBs formed by recombinant prion pro-teins could display infectious properties has important implications On the one hand, bacteria might become
a simple and tunable in vivo system to study the deter-minants of prion formation On the other hand, bacte-rial IBs would be an ideal system for the production
of significant amounts of infectious proteins ready to use for cell biology studies, without the requirement of the highly inefficient in vitro unfolding⁄ refolding and controlled aggregation procedures necessary to obtain proteins in transmissible conformations Therefore, the infectious capacity of prion proteins deposited in bac-teria during recombinant production is receiving increasing attention Meier and co-workers have tested the ability of HET-s PFD IBs purified from E coli to infect strains of its natural host, P anserina, using dif-ferent protein transfection methods [62] Strains trans-fected with HET-s PFD IBs acquired the [Het-s] prion phenotype at a frequency comparable with that obtained with HET-s PFD infectious fibrils assembled
in vitro, confirming that bacterial HET-s PFD IBs dis-play a high prion infectivity [62] In contrast, the IBs
of a heterologous amyloid protein were not infectious The yeast prion protein Sup35 has also been shown recently to access an infectious structure when pro-duced in E coli cells [66] These two independent observations confirm that the content of the bacterial cytoplasm can support the formation of infectious con-formations and suggest that bacterial aggregation might become a generic model system to understand prion biology
Bacteria as model systems to study protein aggregation
In addition to being the default protein production cel-lular factories, bacterial cells are valuable systems to understand the integration of metabolic, regulatory and structural features in living cells The similarities between bacterial aggregates and the deposits formed
in higher organisms in pathological processes like amy-loid fibrils, nuclear inclusions and aggresomes [67,68] provide a unique opportunity to dissect the molecular pathways triggering these disorders in a simple, yet physiologically relevant, organism Accordingly, E coli has been used to study the link between protein aggre-gation and ageing [69], the role of the highly conserved
Trang 7protein quality machinery on the conformational
prop-erties of aggregated states [20,67], the effect of the
pro-tein sequence on in vivo aggregation kinetics [41], the
influence of extrinsic factors like temperature on
pro-tein aggregation properties [21,70] or the control of
polypeptide solubility in biological environments by
the thermodynamic [71] and kinetic stability of
pro-teins [72] In addition, the possibility of labelling
aggregation-prone proteins with natural [41] or
artifi-cial fluorophores [73] allows in vivo deposition
path-ways to be tracked in real time and compounds able
to block the self-assembly process to be identified [74]
Finally, bacteria provide a means to trap and study
the highly toxic, unstable and transient intermediates
in the fibrillation reaction, illuminating one of the
more obscure but crucial steps in amyloid fibril
forma-tion [61]
Acknowledgements
We appreciate the financial support from MICINN
(BFU2010-17450 and BFU2010-14901), AGAUR
(2009SGR-00108 and 2009SGR-00760) and CIBER de
Bioingenierı´a, Biomateriales y Nanomedicina
(CIBER-BBN, Spain), an initiative funded by the VI National
R&D&i Plan 2008–2011, Iniciativa Ingenio 2010,
Con-solider Program, CIBER Actions and financed by the
Instituto de Salud Carlos III with assistance from the
European Regional Development Fund A.V and S.V
have been distinguished with an ICREA Academia
award
References
1 Ferrer-Miralles N, Domingo-Espin J, Corchero JL,
Vazquez E & Villaverde A (2009) Microbial factories
for recombinant pharmaceuticals Microb Cell Fact 8,
17–24
2 Gasser B, Saloheimo M, Rinas U, Dragosits M,
Rodri-guez-Carmona E, Baumann K, Giuliani M, Parrilli E,
Branduardi P, Lang C et al (2008) Protein folding and
conformational stress in microbial cells producing
recombinant proteins: a host comparative overview
Microb Cell Fact 7, 11–28
3 Villaverde A & Carrio´ MM (2003) Protein aggregation
in recombinant bacteria: biological role of inclusion
bodies Biotechnol Lett 25, 1385–1395
4 Sorensen HP & Mortensen KK (2005) Advanced
genetic strategies for recombinant protein expression in
Escherichia coli J Biotechnol 115, 113–128
5 Vallejo LF & Rinas U (2004) Strategies for the recovery
of active proteins through refolding of bacterial
inclu-sion body proteins Microb Cell Fact 3, 11–22
6 Carrio MM & Villaverde A (2001) Protein aggregation
as bacterial inclusion bodies is reversible FEBS Lett
489, 29–33
7 Garcı´a-Fruito´s E, Gonzalez-Montalban N, Morell M, Vera A, Ferraz RM, Aris A, Ventura S & Villaverde A (2005) Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent pro-teins Microb Cell Fact 4, 27–32
8 Carrio´ M, Gonzalez-Montalban N, Vera A, Villaverde
A & Ventura S (2005) Amyloid-like properties of bacte-rial inclusion bodies J Mol Biol 347, 1025–1037
9 Gonzalez-Montalban N, Garcı´a-Fruito´s E & Villaverde
A (2007) Recombinant protein solubility – does more mean better? Nat Biotechnol 25, 718–720
10 Garcı´a-Fruito´s E, Martinez-Alonso M, Gonzalez-Mon-talban N, Valli M, Mattanovich D & Villaverde A (2007) Divergent genetic control of protein solubility and conformational quality in Escherichia coli J Mol Biol 374, 195–205
11 Martinez-Alonso M, Garcı´a-Fruito´s E & Villaverde A (2008) Yield, solubility and conformational quality of soluble proteins are not simultaneously favored in recombinant Escherichia coli Biotechnol Bioeng 101, 1353–1358
12 Garcı´a-Fruito´s E (2010) Inclusion bodies: a new con-cept Microb Cell Fact 9, 80–82
13 Martinez-Alonso M, Gonzalez-Montalban N, Garcı´a-Fruito´s E & Villaverde A (2009) Learning about protein solubility from bacterial inclusion bodies Microb Cell Fact 8, 4–8
14 de Groot NS, Sabate R & Ventura S (2009) Amyloids
in bacterial inclusion bodies Trends Biochem Sci 34, 408–416
15 Sabate R, Espargaro A, Saupe SJ & Ventura S (2009) Characterization of the amyloid bacterial inclusion bodies of the HET-s fungal prion Microb Cell Fact 8, 56–65
16 Carrio´ MM & Villaverde A (2002) Construction and deconstruction of bacterial inclusion bodies J Biotech-nol 96, 3–12
17 Jurgen B, Breitenstein A, Urlacher V, Buttner K, Lin
H, Hecker M, Schweder T & Neubauer P (2010) Qual-ity control of inclusion bodies in Escherichia coli Mic-rob Cell Fact 9, 41–53
18 Vera A, Aris A, Carrio´ M, Gonzalez-Montalban N & Villaverde A (2005) Lon and ClpP proteases participate
in the physiological disintegration of bacterial inclusion bodies J Biotechnol 119, 163–171
19 Carbonell X & Villaverde A (2002) Protein aggregated into bacterial inclusion bodies does not result in protec-tion from proteolytic digesprotec-tion Biotechnology Lett 24, 1939–1944
20 Martinez-Alonso M, Vera A & Villaverde A (2007) Role of the chaperone DnaK in protein solubility and
Trang 8conformational quality in inclusion body-forming
Escherichia colicells FEMS Microbiol Lett 273,
187–195
21 Vera A, Gonzalez-Montalban N, Aris A & Villaverde A
(2007) The conformational quality of insoluble
recombi-nant proteins is enhanced at low growth temperatures
Biotechnol Bioeng 96, 1101–1106
22 Ventura S & Villaverde A (2006) Protein quality in
bacterial inclusion bodies Trends Biotechnol 24, 179–
185
23 Bukau B, Weissman J & Horwich A (2006) Molecular
chaperones and protein quality control Cell 125,
443–451
24 Carrio´ MM & Villaverde A (2005) Localization of
chaperones DnaK and GroEL in bacterial inclusion
bodies J Bacteriol 187, 3599–3601
25 Schlieker C, Tews I, Bukau B & Mogk A (2004)
Solubi-lization of aggregated proteins by ClpB⁄ DnaK relies on
the continuous extraction of unfolded polypeptides
FEBS Lett 578, 351–356
26 Weibezahn J, Bukau B & Mogk A (2004) Unscrambling
an egg: protein disaggregation by AAA+ proteins
Microb Cell Fact 3, 1–12
27 Gonzalez-Montalban N, Garcı´a-Fruito´s E, Ventura S,
Aris A & Villaverde A (2006) The chaperone DnaK
controls the fractioning of functional protein between
soluble and insoluble cell fractions in inclusion
body-forming cells Microb Cell Fact 5, 26–34
28 Gonzalez-Montalban N, Natalello A, Garcı´a-Fruito´s E,
Villaverde A & Doglia SM (2008) In situ protein folding
and activation in bacterial inclusion bodies Biotechnol
Bioeng 100, 797–802
29 Martinez-Alonso M, Garcı´a-Fruito´s E, Ferrer-Miralles
N, Rinas U & Villaverde A (2010) Side effects of
chaperone gene co-expression in recombinant protein
production Microb Cell Fact 9, 64–69
30 Martinez-Alonso M, Gomez-Sebastian S, Escribano
JM, Saiz JC, Ferrer-Miralles N & Villaverde A (2009)
DnaK⁄ DnaJ-assisted recombinant protein production in
Trichoplusia ni larvae Appl Microbiol Biotechnol 86,
633–639
31 de Marco A & Schroedel A (2005) Characterization of
the aggregates formed during recombinant protein
expression in bacteria BMC Biochem 6, 10–20
32 Hamodrakas SJ (2011) Protein aggregation and amyloid
fibril formation prediction software from primary
sequence: towards controlling the formation of bacterial
inclusion bodies FEBS J 278, 2428–2435
33 Ferrer-Miralles N, Martinez-Alonso M, Villaverde A &
Garcı´a-Fruito´s E (2010) Inclusion Bodies: A New
Con-cept of Biocatalysts Protein Aggregation Nova Science
Publishers, New York
34 Garcı´a-Fruito´s E, Aris A & Villaverde A (2007)
Locali-zation of functional polypeptides in bacterial inclusion
bodies Appl Environ Microbiol 73, 289–294
35 Nahalka J, Dib I & Nidetzky B (2008) Encapsulation of Trigonopsis variabilisD-amino acid oxidase and fast comparison of the operational stabilities of free and immobilized preparations of the enzyme Biotechnol Bioeng 99, 251–260
36 Nahalka J & Patoprsty V (2009) Enzymatic synthesis of sialylation substrates powered by a novel polyphosphate kinase (PPK3) Org Biomol Chem 7, 1778–1780
37 Nahalka J (2008) Physiological aggregation of maltod-extrin phosphorylase from Pyrococcus furiosus and its application in a process of batch starch degradation to alpha-D-glucose-1-phosphate J Ind Microbiol Biotech-nol 35, 219–223
38 Nahalka J, Vikartovska A & Hrabarova E (2008) A crosslinked inclusion body process for sialic acid synthe-sis J Biotechnol 134, 146–153
39 Steinmann B, Christmann A, Heiseler T, Fritz J & Kol-mar H (2010) In vivo enzyme immobilization by inclu-sion body display Appl Environ Microbiol 76, 5563– 5569
40 Chiti F, Stefani M, Taddei N, Ramponi G & Dobson
CM (2003) Rationalization of the effects of mutations
on peptide and protein aggregation rates Nature 424, 805–808
41 de Groot NS, Aviles FX, Vendrell J & Ventura S (2006) Mutagenesis of the central hydrophobic cluster
in Abeta42 Alzheimer’s peptide Side-chain properties correlate with aggregation propensities FEBS J 273, 658–668
42 Conchillo-Sole O, de Groot NS, Aviles FX, Vendrell J, Daura X & Ventura S (2007) AGGRESCAN: a server for the prediction and evaluation of ‘hot spots’ of aggregation in polypeptides BMC Bioinformatics 8, 65–81
43 Fernandez-Escamilla AM, Rousseau F, Schymkowitz J
& Serrano L (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins Nat Biotechnol 22, 1302–1306
44 Krebs MR, Morozova-Roche LA, Daniel K, Robinson
CV & Dobson CM (2004) Observation of sequence specificity in the seeding of protein amyloid fibrils Protein Sci 13, 1933–1938
45 Harper JD, Lieber CM & Lansbury PT (1997) Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer’s disease amyloid-beta protein Chem Biol 4, 951–959
46 Jarrett JT & Lansbury PT (1993) Seeding ‘one-dimen-sional crystallization’ of amyloid: a pathogenic mecha-nism in Alzheimer’s disease and scrapie? Cell 73, 1055– 1058
47 Chiti F & Dobson CM (2006) Protein misfolding, func-tional amyloid, and human disease Annu Rev Biochem
75, 333–366
48 Sabate R, Espargaro A, de Groot NS, Valle-Delgado
JJ, Fernandez-Busquets X & Ventura S (2010) The role
Trang 9of protein sequence and amino acid composition in
amyloid formation: scrambling and backward reading
of IAPP amyloid fibrils J Mol Biol 404, 337–352
49 Uversky VN & Fink AL (2004) Conformational
con-straints for amyloid fibrillation: the importance of being
unfolded Biochim Biophys Acta 1698, 131–153
50 Jahn TR & Radford SE (2008) Folding versus
aggrega-tion: polypeptide conformations on competing
path-ways Arch Biochem Biophys 469, 100–117
51 Gatti-Lafranconi P, Natalello A, Ami D, Doglia SM &
Lotti M (2011) Concepts and tools to exploit the
poten-tial of bacterial inclusion bodies in protein science and
biotechnology FEBS J 278, 2408–2418
52 Ecroyd H & Carver JA (2008) Unraveling the mysteries
of protein folding and misfolding IUBMB Life 60,
769–774
53 Merlini G & Bellotti V (2003) Molecular mechanisms of
amyloidosis N Engl J Med 349, 583–596
54 Fowler DM, Koulov AV, Balch WE & Kelly JW (2007)
Functional amyloid – from bacteria to humans Trends
Biochem Sci 32, 217–224
55 Sabate R, de Groot NS & Ventura S (2010) Protein
folding and aggregation in bacteria Cell Mol Life Sci
67, 2695–2715
56 Greenwald J & Riek R (2010) Biology of amyloid:
structure, function, and regulation Structure 18, 1244–
1260
57 Serpell LC, Sunde M, Benson MD, Tennent GA, Pepys
MB & Fraser PE (2000) The protofilament substructure
of amyloid fibrils J Mol Biol 300, 1033–1039
58 Nelson R & Eisenberg D (2006) Recent atomic models
of amyloid fibril structure Curr Opin Struct Biol 16,
260–265
59 Wang L, Maji SK, Sawaya MR, Eisenberg D & Riek R
(2008) Bacterial inclusion bodies contain amyloid-like
structure PLoS Biol 6, e195
60 Morell M, Bravo R, Espargaro A, Sisquella X, Aviles
FX, Fernandez-Busquets X & Ventura S (2008)
Inclu-sion bodies: specificity in their aggregation process and
amyloid-like structure Biochim Biophys Acta 1783,
1815–1825
61 Dasari M, Espargaro A, Sabate R, Lo´pez del Amo J,
Fink U, Grelle G, Bieschke J, Ventura S & Reif B
(2011) Bacterial inclusion bodies of the alzheimer
dis-ease beta-amyloid peptides can be employed to study
native like aggregation intermediate states Chem Bio Chem 12, 407–423
62 Wasmer C, Benkemoun L, Sabate R, Steinmetz MO, Coulary-Salin B, Wang L, Riek R, Saupe SJ & Meier
BH (2009) Solid-state NMR spectroscopy reveals that
E coliinclusion bodies of HET-s(218-289) are amy-loids Angew Chem Int Ed Engl 48, 4858–4860
63 Thompson LK (2003) Unraveling the secrets of Alzhei-mer’s beta-amyloid fibrils Proc Natl Acad Sci USA
100, 383–385
64 Tycko R (2006) Molecular structure of amyloid fibrils: insights from solid-state NMR Q Rev Biophys 39, 1–55
65 Wasmer C, Lange A, Van Melckebeke H, Siemer AB, Riek R & Meier BH (2008) Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core Science 319, 1523–1526
66 Garrity SJ, Sivanathan V, Dong J, Lindquist S & Hochschild A (2010) Conversion of a yeast prion pro-tein to an infectious form in bacteria Proc Natl Acad Sci USA 107, 10596–10601
67 Woulfe J (2008) Nuclear bodies in neurodegenerative disease Biochim Biophys Acta 1783, 2195–2206
68 Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation Trends Cell Biol 10, 524–530
69 Lindner AB, Madden R, Demarez A, Stewart EJ & Taddei F (2008) Asymmetric segregation of protein aggregates is associated with cellular aging and rejuve-nation Proc Natl Acad Sci USA 105, 3076–3081
70 de Groot NS & Ventura S (2006) Effect of temperature
on protein quality in bacterial inclusion bodies FEBS Lett 580, 6471–6476
71 Espargaro A, Sabate R & Ventura S (2008) Kinetic and thermodynamic stability of bacterial intracellular aggre-gates FEBS Lett 582, 3669–3673
72 Castillo V, Espargaro A, Gordo V, Vendrell J & Ven-tura S (2010) Deciphering the role of the thermody-namic and kinetic stabilities of SH3 domains on their aggregation inside bacteria Proteomics 10, 4172–4185
73 Ignatova Z & Gierasch LM (2004) Monitoring protein stability and aggregation in vivo by real-time fluorescent labeling Proc Natl Acad Sci USA 101, 523–528
74 Kim W, Kim Y, Min J, Kim DJ, Chang YT & Hecht
MH (2006) A high-throughput screen for compounds that inhibit aggregation of the Alzheimer’s peptide ACS Chem Biol 1, 461–469